Exploratory analysis of the effect of taselisib on downstream pathway modulation and correlation with tumor response in ER-positive/HER2-negative early-stage breast cancer from the LORELEI trial Meeting Abstract


Authors: Nuciforo, P.; Hlauschek, D.; Saura, C.; de Azambuja, E.; Fasani, R.; Villagrasa, P.; Muehlbacher, K.; Sotiriou, C.; Prat, A.; Pfeiler, G.; Hilbers, F.; Wilson, T. R.; Aimi, J.; Stout, T.; Valero, V.; Fesl, C.; Baselga, J.; Gnant, M.; Piccart, M.; Andre, F.
Abstract Title: Exploratory analysis of the effect of taselisib on downstream pathway modulation and correlation with tumor response in ER-positive/HER2-negative early-stage breast cancer from the LORELEI trial
Meeting Title: 55th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 37
Issue: 15 Suppl.
Meeting Dates: 2019 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2019-05-20
Start Page: 46s
Language: English
ACCESSION: WOS:000487345804008
DOI: 10.1200/JCO.2019.37.15_suppl.1050
PROVIDER: wos
Notes: Meeting Abstract: 1050 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jose T Baselga
    484 Baselga